Insulin aspart, recombinant Subcutaneous and Lansoprazole
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lansoprazole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lansoprazole
Brand name: FIRST Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lansoprazole Delayed-Release Capsules
- Insulin aspart, recombinant Subcutaneous-Lansoprazole Orally Disintegrating Tablets
- Insulin aspart, recombinant Subcutaneous-Lansoprazole, Amoxicillin, and Clarithromycin
- Insulin aspart, recombinant Subcutaneous-Lanthanum
- Insulin aspart, recombinant Subcutaneous-Lanthanum carbonate
- Insulin aspart, recombinant Subcutaneous-Lanthanum Carbonate Tablets
- Lansoprazole-Insulin degludec
- Lansoprazole-Insulin Degludec (U-100) Prefilled Pens
- Lansoprazole-Insulin Degludec (U-100) Vials
- Lansoprazole-Insulin Degludec (U-200) Prefilled Pens
- Lansoprazole-Insulin degludec and liraglutide
- Lansoprazole-Insulin degludec and liraglutide Subcutaneous